交大昂立(600530.SH):2022年度預虧1億元 同比盈轉虧
格隆匯1月30日丨交大昂立(600530.SH)公佈,公司預計2022年年度實現歸屬於母公司所有者的淨利潤約為-1億元,同比減少約369%(未經審計)。預計2022年年度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤約為-1.15億元,同比減少約554%(未經審計)。
2022年,公司全資孫公司霍爾果斯仁恆醫養管理有限公司管理的各民非機構收入及利潤較上年有所下滑,同時仁恆醫養調整了向各民非機構收取的管理費。
根據財政部《企業會計準則》,以及中國證監會發布的《會計監管風險提示第8號-商譽減值》文件要求,公司對收購全資子公司上海仁杏健康管理有限公司股權所形成的商譽及經營收益權在內的資產組進行了初步減值測試,根據外部環境變化對經營業務的影響,綜合考慮子公司經營狀況及發展預期等因素,初步判斷上述資產存在減值跡象。最終資產減值準備計提的金額需依據評估機構出具的資產減值測試評估報吿以及會計師事務所審計確定。
公司全資孫公司上海昂立久鼎典當有限公司對上海興浦服裝有限公司發放的當金預計收回可能性極小,需全額計提減值準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.